AI assistant
FREIGHTWAYS GROUP LIMITED — Director's Dealing 2026
Mar 11, 2026
64946_rns_2026-03-11_a6806dc6-ad62-4465-8263-175d72fdb36d.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [107 x 29] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 |
||
|---|---|---|
| To NZX Limited | ||
| Name of listed issuer: | Freightways GroupLimited | |
| Date this disclosure made: | 12 March 2026 | |
| Date of last disclosure: | 2 March 2026 | |
| Director or senior manager giving disclosure | ||
| Full name(s): | Stephan Deschamps | |
| Name of listed issuer: | Freightways GroupLimited | |
| Name of related body corporate (if applicable): | n/a | |
| Position held in listed issuer: | Chief Financial Officer | |
| Summary of acquisition or disposal of relevant interest (excluding specified derivatives) | ||
| Class of affected quoted financial products: | Fully paid ordinary shares | |
| Nature of the affected relevant interest(s): | Beneficial relevant interest | |
| For that relevant interest- | ||
| Number held in class before acquisition or disposal: | (a) 32,279 fully paid ordinary shares (b) 50,410 share rights |
|
| Number held in class after acquisition or disposal: | (a) 27,625 fully paid ordinary shares (b) 50,410 share rights |
|
| Current registered holder(s): | Stephan Deschamps | |
| Registered holder(s) once transfers are registered: | Stephan Deschamps | |
| Summary of acquisition or disposal of specified derivatives relevant interest (if applicable) | ||
| Type of affected derivative: | n/a | |
| Class of underlyingfinancial products: | n/a | |
| Details of affected derivative- | ||
| The notional value of the derivative (if any) or the notional amount of underlying financial products(if any): |
n/a | |
| A statement as to whether the derivative is cash settled or physicallysettled: | n/a | |
| Maturitydate of the derivative(if any): | n/a | |
| Expirydate of the derivative(if any): | n/a | |
| The price specified in the terms of the derivative (if any): | n/a | |
| Any other details needed to understand how the amount of the consideration payable | ||
| under the derivative or the value of the derivative is affected by the value of the underlying | n/a | |
| financialproducts: | ||
| _For that derivative,- _ | ||
| Parties to the derivative: | n/a | |
| If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative: |
n/a | |
| Details of transactions giving rise to acquisition or disposal- | ||
| Total number of transactions to which notice relates: | Four(4) |
Details of transactions requiring disclosure-
1) 5 March 2026 2) 6 March 2026 3) 10 March 2026 4) 10 March 2026 On market sale of fully paid ordinary shares to fund tax obligations relating to recently vested performance share rights
Date of transaction: Nature of transaction: Name of any other party or parties to the transaction (if known): The consideration, expressed in New Zealand dollars, paid or recieved for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value, describe the consideration: Number of financial products to which the transaction related: If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details— Whether relevant interests were aquired or disposed of during a closed period: Whether prior written clearance was provided to allow the aquisition or disposal to proceed during the closed period: Date of the prior written clearance (if any):
n/a 1) $2,622.60 (being $14.10 per share) 2) $28,000 (being $14 per share) 3) $6,552 (being $14 per share) 4) $27,800 (being $13.90 per share) 1) 186 fully paid ordinary shares 2) 2,000 fully paid ordinary shares 3) 468 fully paid ordinary shares 4) 2,000 fully paid ordinary shares
No n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
| Class of financial products: Nature of relevant interest: For that relevant interest,- Number held in class: Current registered holder(s): Class of financial products: Nature of relevant interest: For that relevant interest,- Number held in class: Current registered holder(s): For a derivative relevant interest,- Summary of other relevant interests after acquisition or disposal: |
Class of financial products: Nature of relevant interest: For that relevant interest,- Number held in class: Current registered holder(s): Class of financial products: Nature of relevant interest: For that relevant interest,- Number held in class: Current registered holder(s): For a derivative relevant interest,- Summary of other relevant interests after acquisition or disposal: |
|
|---|---|---|
| n/a | ||
| n/a | ||
| n/a | ||
| n/a | ||
| n/a | ||
| n/a | ||
| n/a | ||
| n/a | ||
| Type of derivative: | n/a | |
| Details of derivative- | ||
| The notional value of the derivative (if any) or the notional amount of underlying financial products(if any): |
n/a | |
| A statement as to whether the derivative is cash settled or physically settled: | n/a | |
| Maturity date of the derivative (if any): | n/a | |
| Expiry date of the derivative (if any): | n/a | |
| The price's specified terms (if any): | n/a | |
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: |
n/a | |
| Parties to the derivative: | n/a | |
| If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative: |
n/a |
Certification
I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made.
Signature of person authorised to sign on behalf of director or officer: Date of signature: 12 March 2026 Stephan Deschamps Name and title of authorised person: Chief Financial Officer